Evidence map›Paper›PMID 31048873›Full record

Observational studyPloS one2019

Prevalence of thyroid dysfunction in older Chinese patients with type 2 diabetes-A multicenter cross-sectional observational study across China.

Yu Zhu, Fengmei Xu, Jie Shen, Youshuo Liu, Changhua Bi, Jing Liu, Yufeng Li, Xueqin Wang, Zhengnan Gao, Linlang Liang and 16 more

Open access · goldAbstract readMulticenter StudyObservational Study
In one paragraph

Observational study in PloS one, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed, 1 pooled it
3.2field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 1 synthesis or guideline pooled it, 42 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Influence of Low Total Triiodothyronine Levels on Bone Turnover Markers in Type 2 Diabetes Mellitus.Diabetes, metabolic syndrome and obesity : targets and therapy · 2021
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

26 authors at 18 institutions in 1 country.

Yu ZhuPeking University People's Hospital, Beijing, China.ORCID 0000-0001-7615-2674
Fengmei XuGeneral Hospital of Hebi Coal Industry [Group] Co., Ltd., Hebi, China.
Jie ShenThe Third Affiliated Hospital of Southern Medical University, Guangzhou, China.
Youshuo LiuThe Second Xiangya Hospital of Central South University, Changsha, China.
Changhua BiCNPC Central Hospital, Hebei, China.
Jing LiuGansu Provincial Hospital, Lanzhou, China.
Yufeng LiBeijing Pinggu Hospital, Beijing, China.
Xueqin WangBeijing Huairou Hospital of University of Chinese Academy Sciences, Beijing, China.
Zhengnan GaoDalian Municipal Central Hospital Affiliated of Dalian Medical University, Dalian, China.
Linlang LiangThe General Hospital of Shenyang Military Region, Shenyang, China.
Yanyan ChenFuwai Hospital Chinese Academy of Medical Sciences, Beijing, China.
Weiping SunThe First People's Hospital of Xiangtan City, Xiangtan, China.
Qingbo GuanShandong Provincial Hospital, Shandong, China.
Junqing ZhangPeking University First Hospital, Beijing, China.
Zuojie LuoThe First Affiliated Hospital of Guangxi Medical University, Guangxi, China.
Lixin GuoBeijing Hospital, Beijing, China.
Xiaopin CaiChina-Japan Friendship Hospital, Beijing, China.
Ling LiShengjing Hospital of China Medical University, Shenyang, China.
Lingling XiuFirst Affiliated Hospital of Sun Yat-sen University, Guangzhou, China.
Li YanSun Yat-sen Memorial Hospital of Sun Yat-sen University, Guangzhou, China.
Chunlin LiThe General Hospital of the People's Liberation Army [301 Hospital], Beijing, China.
Xiaoyun ShiThe General Hospital of Chinese People's Armed Police Forces, Beijing, China.
Mei ZhuGeneral Hospital, Tianjin Medical University, Tianjin, China.
Jian KuangGuangdong General Hospital, Guangzhou, China.
Guangwei LiFuwai Hospital Chinese Academy of Medical Sciences, Beijing, China.
Linong JiPeking University People's Hospital, Beijing, China.ORCID 0000-0002-2088-9690
Peking University · CNChinese Academy of Medical Sciences & Peking Union Medical College · CNSun Yat-sen University · CNBeijing Anding Hospital · CNBeijing Hospital · CNCentral South University · CNChina-Japan Friendship Hospital · CNChina Medical University · CNChina National Petroleum Corporation (China) · CNChinese People's Armed Police General Hospital · CNDalian Medical University · CNGansu Provincial Hospital · CNGeneral Hospital of Shenyang Military Region · CNGuangdong General Hospital · CNGuangxi Medical University · CNShandong Provincial Hospital · CNThird Affiliated Hospital of Southern Medical University · CNTianjin Medical University General Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Type 2 diabetes [T2D] and thyroid dysfunction [TD] often co-occur, have overlapping pathologies, and their risk increases with age. Since 1995, universal salt iodization has been implemented in China to prevent disorders caused by iodine deficiency. However, after two decades of implementation of universal salt iodization, the prevalence of TD in elderly Chinese patients with T2D is not well described and may have been underestimated. We conducted a questionnaire-based survey across 24 endocrinology centers in China between December 2015 and July 2016. Demographic and clinical data from 1677 patients with T2D were obtained and analyzed to examine the prevalence of TD along with T2D in these patients. We assessed TD prevalence according to the four TD subtypes [subclinical hypothyroidism, clinical hypothyroidism, subclinical hyperthyroidism, and clinical hyperthyroidism], TD history, gender, and age. The diagnosis rates were calculated for TD and also for the TD subtype. The number of patients reaching treatment goals for T2D [hemoglobin A1c <7%] and TD [normal free thyroxine and thyroid-stimulating hormone [TSH]] and the incidences of complications and comorbidities were recorded. Among the enrolled patients with T2D [N = 1677], TD was diagnosed in 23.79% [399/1677] out of which 61% (245/399) were previously diagnosed and 38.59% (154/399) were newly diagnosed cases. Subclinical hypothyroidism, clinical hypothyroidism, subclinical hyperthyroidism, and clinical hyperthyroidism were reported in 4.89%, 9.3%, 1.13%, and 3.16% of the total population, respectively. Among patients previously diagnosed with TD, the incidence in women [166/795; 20.88%] was higher than in men [79/882; 8.96%]. The treatment goals for TD and T2D were attained in 39.6% [97/245] and 34.41% [577/1677] of the cases, respectively. Diabetic complications and comorbidities were reported in 99.7% of patients, with peripheral neuropathy being the most common [43.46%] followed by cataract [24.73%]. We had found that the incidences of dyslipidemia, elevated LDL levels, and osteoporosis were significantly higher in patients with TD than those without TD. TD is underdiagnosed in elderly Chinese patients with T2D.

Indexed as

AgedAsian PeopleChinaCross-Sectional StudiesDiabetes Mellitus, Type 2FemaleHumansHyperthyroidismHypothyroidismMaleMiddle AgedPrevalenceSurveys and QuestionnairesThyroid DiseasesThyroid Gland

Identifiers

PMID31048873
PMCPMC6497275
OpenAlexW2943653313

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.